The latest news from Arcinova
C&EN ArticleFollowing a visit to Alnwick and a tour of Arcinova's facilities, Alex Scott wrote an article in the May 30th 2016 edition of C&EN, outlining the acquisition story and the growth prospects for
Welcome to Mark ChadwickMark joins Arcinova from AIM-listed Physiomics plc, where he was CEO for 5 years. Mark’s previous roles include CEO of Envirogene and VP of Business Development at Excelsyn. Before joining Exc
Evening Chronicle ArticleLast month the Evening Chronicle featured an article regarding the formation of ARC Trinova & Arcinova. The article explains that the formation of ARC Trinova, trading as Arcinova, has saved f
New company, new websiteArcinova is set to make some exciting changes to the existing business and site. Not only will there be restructuring and physical changes but we've also commissioned this brand new website to let
Press ReleaseARC Trinova is acquiring site in Alnwick to form International Contract Research and Development Business. Arc Trinova, a new company formed by Ian Shott and Paul Ryan, owners of Shott Tri
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.